Search Results - "Vardiman, J"

Refine Results
  1. 1

    Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms by Tefferi, A, Vardiman, J W

    Published in Leukemia (01-01-2008)
    “…The 2001 World Health Organization (WHO) treatise on the classification of hematopoietic tumors lists chronic myeloproliferative diseases (CMPDs) as a…”
    Get full text
    Journal Article
  2. 2

    Instrument-assisted soft tissue mobilization: effects on the properties of human plantar flexors by Vardiman, J P, Siedlik, J, Herda, T, Hawkins, W, Cooper, M, Graham, Z A, Deckert, J, Gallagher, P

    Published in International journal of sports medicine (01-03-2015)
    “…The effect of instrument-assisted soft tissue mobilization (ISTM) on passive properties and inflammation in human skeletal muscle has not been evaluated…”
    Get more information
    Journal Article
  3. 3
  4. 4

    The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues by Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., Bloomfield, C. D.

    Published in Annals of oncology (01-12-1999)
    “…Introduction: Since 1995, the European Association of Pathologists (EAHP) and the Society for Hematopathology (SH) have been developing a new World Health…”
    Get full text
    Journal Article
  5. 5

    The change in motor unit firing rates at de-recruitment relative to recruitment is correlated with type I myosin heavy chain isoform content of the vastus lateralis in vivo by Herda, T. J., Miller, J. D., Trevino, M. A., Mosier, E. M., Gallagher, P. M., Fry, A. C., Vardiman, J. P.

    Published in Acta Physiologica (01-04-2016)
    “…Aim To investigate the change in motor unit (MU) firing rates (FR) at de‐recruitment relative to recruitment and the relation to % type I myosin heavy chain…”
    Get full text
    Journal Article
  6. 6

    The World Health Organization classification of neoplastic diseases of the hematopoietic and Lymphoid tissues : Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997 by HARRIS, N. L, JAFFE, E. S, DIEBOLD, J, FLANDRIN, G, MULLER-HERMELINK, H. K, VARDIMAN, J, LISTER, T. A, BLOOMFIELD, C. D

    Published in Annals of oncology (01-12-1999)
    “…Since 1995, the European Association of Pathologists (EAHP) and the Society for Hematopathology (SH) have been developing a new World Health Organization (WHO)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A Reliable Method for Assessing Rotational Power by Andre, Matthew J, Fry, Andrew C, Heyrman, Melissa A, Hudy, Andrea, Holt, Brady, Roberts, Cody, Vardiman, J. Phillip, Gallagher, Philip M

    “…Andre, MJ, Fry, AC, Heyrman, MA, Hudy, A, Holt, B, Roberts, C, Vardiman, JP, and Gallagher, PM. A reliable method for assessing rotational power. J Strength…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Lymphoma classification : from controversy to consensus : The R.E.A.L. and WHO Classification of lymphoid neoplasms by HARRIS, N. L, JAFFE, E. S, DIEBOLD, J, FLANDRIN, G, MULLER-HERMELINK, H. K, VARDIMAN, J

    Published in Annals of oncology (2000)
    “…Controversy in lymphoma classification dates back to the first attempts to formulate such classifications. Over the years, much of this controversy arose from…”
    Get full text
    Conference Proceeding Journal Article
  11. 11

    Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome by Cheng, J X, Anastasi, J, Watanabe, K, Kleinbrink, E L, Grimley, E, Knibbs, R, Shen, Q J, Vardiman, J W

    Published in Leukemia (01-06-2013)
    “…Cytogenetically normal myelodysplastic syndrome (CN-MDS) can pose diagnostic challenges and its pathogenetic mechanism remains elusive. By focusing on…”
    Get full text
    Journal Article
  12. 12

    The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 by Harris, N L, Jaffe, E S, Diebold, J, Flandrin, G, Muller-Hermelink, H K, Vardiman, J, Lister, T A, Bloomfield, C D

    Published in Histopathology (01-01-2000)
    “…Introduction Since 1995, the European Association of Pathologists (EAHP) and the Society for Hematopathology (SH) have been developing a new World Health…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: A forgotten pearl by Thiele, J., Kvasnicka, H.M., Vardiman, J.

    “…Histopathology of bone marrow (BM) biopsies plays a crucial role in the interdisciplinary approach to diagnosis and classification of chronic…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes by Vardiman, James W., Thiele, Jüergen, Arber, Daniel A., Brunning, Richard D., Borowitz, Michael J., Porwit, Anna, Harris, Nancy Lee, Le Beau, Michelle M., Hellström-Lindberg, Eva, Tefferi, Ayalew, Bloomfield, Clara D.

    Published in Blood (30-07-2009)
    “…Recently the World Health Organization (WHO), in collaboration with the European Association for Haematopathology and the Society for Hematopathology,…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211 by BYRD, I. C, PETERSON, B, PIRO, L, SAVEN, A, VARDIMAN, J. W, LARSON, R. A, SCHIFFER, C

    Published in Leukemia (01-02-2003)
    “…Cladribine has been reported to have little activity in fludarabine- refractory chronic lymphocytic leukemia (CLL). We sought to determine whether resistance…”
    Get full text
    Journal Article
  17. 17

    Diagnostic criteria and classification of mastocytosis: a consensus proposal by Valent, Peter, Horny, Hans-P, Escribano, Luis, Longley, B.Jack, Li, Chin Y, Schwartz, Lawrence B, Marone, Gianni, Nuñez, Rosa, Akin, Cem, Sotlar, Karl, Sperr, Wolfgang R, Wolff, Klaus, Brunning, Richard D, Parwaresch, Reza M, Austen, K.Frank, Lennert, Karl, Metcalfe, Dean D, Vardiman, James W, Bennett, John M

    Published in Leukemia research (01-07-2001)
    “…The term ‘mastocytosis’ denotes a heterogeneous group of disorders characterized by abnormal growth and accumulation of mast cells (MC) in one or more organ…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome by Rosati, S, Mick, R, Xu, F, Stonys, E, Le Beau, M M, Larson, R, Vardiman, J W

    Published in Leukemia (01-01-1996)
    “…Myelodysplastic syndromes (MDS) characterized by multilineage cytopenias and dysplasia but lacking an increase in blasts, with no Auer rods or monocytosis, do…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Hematopathologic findings in the myeloproliferative disorders by Dickstein, J I, Vardiman, J W

    Published in Seminars in oncology (01-08-1995)
    “…In the preceding paragraphs, the features that define the various members of the CMPD have been reviewed. These features are summarized in Table 4. Knowledge…”
    Get more information
    Journal Article